论文部分内容阅读
对116例垂体腺癌进行回顾性总结。垂体腺疗占同期颅内肿瘤的11．3％。女性病人多以月经紊乱就诊（91．3％），男性病人则多以视力下降就诊（93．6％）。血清PRL增高80．4％。颅骨X片示鞍窝扩大97例（83．6％），伴后床突骨质疏松76例（78．3％）。CT平扫肿瘤呈低密度64例（55．2％），等密度38例（32．7％），高密度14例（12．1％）。MRIT1加权呈略低信号58．1％，等信号37．7％。T2加权均呈高信号。全组手术治疗108例，术后视力改善69例（88．4％），泌乳停止20例（57．5％），月经恢复6例（8．9％），脑室扩大14例恢复正常（78．7％）
A retrospective review of 116 pituitary adenocarcinomas was performed. Pituitary glands accounted for 11.3% of intracranial tumors during the same period. Most of the female patients were diagnosed with menstrual disorders (91.3%), while male patients were often treated with decreased vision (93.6%). The serum PRL increased by 80.4%. Skull X films showed that the saddle was expanded in 97 cases (83.6%) with osteopenia in the posterior olecranon in 76 cases (78.3%). CT plain scan showed low density in 64 cases (55.2%), equal density in 38 cases (32.7%), and high density in 14 cases (12.1%). MRIT1 weighted a slightly lower signal of 58.1% and equal signal 37.7%. T2 weighted high signal. 108 cases were treated with surgery in the whole group. Postoperative visual acuity was improved in 69 cases (88.4%), lactation was stopped in 20 cases (57.5%), menstruation was recovered in 6 cases (8.9%), and ventricles were expanded in 14 cases. .7%)